BCL2 and neoplasm: The fact that levels of the anti-apoptotic protein BCL-2 are only reduced on average by 40% suggests that either there are other as yet undiscovered targets of MM41, or possibly that this level of BCL-2 decrease is sufficient to drive tumour cells to apoptosis.